CN111848423A - Preparation method of tert-butyl 3-oxocyclobutylcarbamate - Google Patents
Preparation method of tert-butyl 3-oxocyclobutylcarbamate Download PDFInfo
- Publication number
- CN111848423A CN111848423A CN201910360376.6A CN201910360376A CN111848423A CN 111848423 A CN111848423 A CN 111848423A CN 201910360376 A CN201910360376 A CN 201910360376A CN 111848423 A CN111848423 A CN 111848423A
- Authority
- CN
- China
- Prior art keywords
- compound
- acid
- unsubstituted
- tert
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- FNHPTFKSPUTESA-UHFFFAOYSA-N tert-butyl n-(3-oxocyclobutyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1CC(=O)C1 FNHPTFKSPUTESA-UHFFFAOYSA-N 0.000 title claims abstract description 14
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 15
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims abstract description 12
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- 238000006731 degradation reaction Methods 0.000 claims abstract description 7
- 238000010511 deprotection reaction Methods 0.000 claims abstract description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 11
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims description 5
- 239000003377 acid catalyst Substances 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical group [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- CRWJEUDFKNYSBX-UHFFFAOYSA-N sodium;hypobromite Chemical compound [Na+].Br[O-] CRWJEUDFKNYSBX-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- -1 compound tert-butyl 3-oxocyclobutylcarbamate Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 18
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical compound NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000004537 pulping Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- IENOFRJPUPTEMI-UHFFFAOYSA-N 3-oxocyclobutane-1-carboxylic acid Chemical compound OC(=O)C1CC(=O)C1 IENOFRJPUPTEMI-UHFFFAOYSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- SGJBIFUEFLWXJY-UHFFFAOYSA-N 1-(dibutoxymethoxy)butane Chemical compound CCCCOC(OCCCC)OCCCC SGJBIFUEFLWXJY-UHFFFAOYSA-N 0.000 description 1
- RWNXXQFJBALKAX-UHFFFAOYSA-N 1-(dipropoxymethoxy)propane Chemical compound CCCOC(OCCC)OCCC RWNXXQFJBALKAX-UHFFFAOYSA-N 0.000 description 1
- ZRWMAMOBIQQJSA-UHFFFAOYSA-N 3-methylidenecyclobutane-1-carbonitrile Chemical compound C=C1CC(C#N)C1 ZRWMAMOBIQQJSA-UHFFFAOYSA-N 0.000 description 1
- VYBHECRBRRNEPG-UHFFFAOYSA-N C1(CC(C1)=O)C(=O)O.C(N)(OC(C)(C)C)=O Chemical compound C1(CC(C1)=O)C(=O)O.C(N)(OC(C)(C)C)=O VYBHECRBRRNEPG-UHFFFAOYSA-N 0.000 description 1
- 229940123628 Lysine (K)-specific demethylase 1A inhibitor Drugs 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- UYLSVYARXBFEKV-UHFFFAOYSA-N cyclobutane-1,3-diamine Chemical compound NC1CC(N)C1 UYLSVYARXBFEKV-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002062 molecular scaffold Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention belongs to the technical field of medicines, and particularly relates to a preparation method of tert-butyl 3-oxocyclobutyl carbamate (I), which comprises the following steps: and protecting the compound IV to generate a compound III, performing Hofmann degradation reaction to obtain a compound II, and finally performing deprotection to obtain a compound I. Compared with the prior art, the method has the advantages of low cost of the technical route, mild reaction conditions, no use of toxic reagents with large risk coefficients, environmental protection and good application value.
Description
The technical field is as follows:
the invention belongs to the technical field of medicines, and particularly relates to a preparation method of tert-butyl 3-oxocyclobutylcarbamate.
Background art:
aminocyclobutane, as an important molecular scaffold, is widely used in the design of new drug molecules, such as drugs for treating hepatitis c virus infection (WO 2013064538); LSD1 inhibitors containing an aminocyclobutane skeleton (WO 2013057322); aminocyclobutane-containing JAK and SYK inhibitors (WO 2013030138); 1, 3-cyclobutanediamine containing aminocyclobutane (CN 104829492); aminocyclobutane containing elvan intermediate (WO2015010297, WO2013107291 and WO 2013107405). And tert-butyl 3-oxocyclobutylcarbamate (CAS number: 154748-49-9) having an aminocyclobutane structure is an important intermediate for synthesizing such compounds. There are several publications reporting the synthesis of tert-butyl 3-oxocyclobutylcarbamate.
Patents WO2015010297, WO2013107291 and WO2013107405 all disclose processes for the preparation of tert-butyl 3-oxocyclobutylcarbamate starting from 3-oxocyclobutanecarboxylic acid, the route being as in Scheme 1.
The 3-oxocyclobutanecarboxylic acid is used as a raw material, and tert-butyl 3-oxocyclobutyl carbamate is obtained through three reactions of chlorination, substitution and rearrangement. Column chromatography purification is used for a plurality of times in the reaction process, and NaN is used3And the like, and is not suitable for industrial production.
Patent WO2017019589 discloses a process for preparing tert-butyl 3-oxocyclobutylcarbamate from 3-oxocyclobutanecarboxylic acid as a starting material, the route being shown in Scheme 2.
The 3-oxocyclobutanecarboxylic acid is used as a raw material in the route, although the 3-oxocyclobutanecarboxylic acid tert-butyl carbamate is obtained through one-step reaction, the yield is only 47%, and the requirement of industrial production cannot be met.
Patents WO2011044503, WO2010147836, WO2010132777 and the like disclose methods for preparing tert-butyl 3-oxocyclobutylcarbamate from 3-methylenecyclobutylcarbonitrile as a raw material, and routes are shown in Scheme 3.
The 3-oxocyclobutylcarbamic acid tert-butyl ester is obtained by using 3-methylenecyclobutylnitrile as a raw material through three-step reaction in the route, the yield is extremely low and is only 25%, and NaN is used 3And the like, and is not suitable for industrial production.
The invention content is as follows:
in order to overcome the defects in the prior art, the invention discloses a preparation method of tert-butyl 3-oxocyclobutylcarbamate.
The specific process route is as follows:
wherein R is halogen substituted or unsubstituted C1-C6 alkyl, unsubstituted C3-C6 cycloalkyl, unsubstituted benzyl, or benzyl substituted with halogen.
In order to achieve the purpose, the invention adopts the following technical scheme:
step a): the compound IV is protected to generate a compound III,
step b): carrying out Hoffman degradation reaction on the compound III to obtain a compound II,
step c): deprotection of compound II produces compound I.
Further, R in the scheme is methyl or ethyl, preferably ethyl.
Further, the compound IV in step a) is reacted with trimethyl orthoformate or triethyl orthoformate to give compound III, preferably triethyl orthoformate.
Further, the reaction of step a) is carried out under the action of a catalyst selected from sulfuric acid, p-toluenesulfonic acid, benzenesulfonic acid, acetic acid, preferably p-toluenesulfonic acid.
Further, an oxidant is used in the Hofmann degradation reaction in the step b), and the oxidant is selected from NaClO, NaBrO and Br 2NaOH, preferably NaClO.
Further, the hofmann degradation reaction of step b) is carried out in an organic solvent selected from tetrahydrofuran, dichloromethane, 1, 4-dioxane, preferably tetrahydrofuran.
Further, the deprotection reaction in the step c) is carried out under the condition of an acid catalyst, and the acid catalyst is selected from hydrochloric acid and sulfuric acid.
Further, the acid concentration in the deprotection reaction of step c) is selected from 0.1 to 1mol/L, preferably 0.5 to 1 mol/L.
Compared with the prior art, the method has the advantages of low cost of the used technical route, mild reaction conditions, no use of toxic reagents with large risk coefficients, environmental friendliness, high yield and suitability for industrial production.
Drawings
Process for preparation of compound III of FIG. 11HNMR picture
FIG. 2 Process for preparation of Compound II1HNMR picture
FIG. 3 Process for preparation of Compound I1HNMR picture
Detailed Description
The technical content of the present invention is further described below with reference to specific examples for better understanding of the content of the present invention, but the scope of the present invention is not limited thereto.
EXAMPLE 1 preparation of Compound III
Adding 50g of compound IV into 200mL of ethanol, then adding 3.8g of p-toluenesulfonic acid, cooling to 0-5 ℃, dropwise adding 79g of triethyl orthoformate, reacting at room temperature for 20h after completing dropwise adding, and tracking by TLC until the reaction is completed. Extracting with dichloromethane, concentrating to dryness, adding 50mL methyl tert-butyl ether, pulping, filtering, washing, and oven drying to obtain white solid 75g, with yield 91% and purity 98%. 1The H NMR data are shown in FIG. 1.
EXAMPLE 2 preparation of Compound III
Adding 50g of compound IV into 200mL of ethanol, then adding 2.2g of concentrated sulfuric acid, cooling to 0-5 ℃, dropwise adding 79g of triethyl orthoformate, reacting at room temperature for 20h after the dropwise adding is finished, and tracking by TLC until the reaction is finished. Extracting with dichloromethane, concentrating to dryness, adding 50mL methyl tert-butyl ether, pulping, filtering, washing, and oven drying to obtain white solid 71g, with yield of 86% and purity of 98%.
EXAMPLE 3 preparation of Compound III
Adding 50g of compound IV into 200mL of methanol, then adding 3.8g of p-toluenesulfonic acid, cooling to 0-5 ℃, slowly dripping 57g of trimethyl orthoformate, reacting at room temperature for 20h after dripping, and tracking by TLC until the reaction is finished. Extracting with dichloromethane, concentrating to dryness, adding 50mL methyl tert-butyl ether, pulping, filtering, washing, and oven drying to obtain 62g white solid with yield of 88% and purity of 98%.
EXAMPLE 4 preparation of Compound III
Adding 50g of compound IV into 200mL of ethanol, then adding 2.2g of concentrated sulfuric acid, cooling to 0-5 ℃, dropwise adding 100g of tripropylorthoformate, reacting at room temperature for 20h after the dropwise addition is finished, and tracking by TLC until the reaction is finished. Extracting with dichloromethane, concentrating to dryness, adding 50mL methyl tert-butyl ether, pulping, filtering, washing, and drying to obtain 57g white solid.
EXAMPLE 5 preparation of Compound III
Adding 50g of compound IV into 200mL of ethanol, then adding 2.2g of concentrated sulfuric acid, cooling to 0-5 ℃, dropwise adding 123g of tributyl orthoformate, reacting at room temperature for 20h after the dropwise adding is finished, and tracking by TLC until the reaction is finished. Extracting with dichloromethane, concentrating to dryness, adding 50mL methyl tert-butyl ether, pulping, filtering, washing, and drying to obtain 62g of white solid.
EXAMPLE 6 preparation of Compound II
50g of the compound III obtained in example 1 was added to 200mL of tetrahydrofuran, cooled to 0 ℃, and then 21g of sodium hydroxide was dissolved in 240g of a sodium hypochlorite (10%) solution and added dropwise to the reaction system. And (3) carrying out reaction at 0-5 ℃, tracking by TLC until the reaction is finished, then adding 58g of di-tert-butyl dicarbonate, tracking by TLC until the reaction is finished, extracting by using dichloromethane, concentrating to dryness to obtain 66g of a crude product of the compound II, and directly using the crude product in the next step.1The H NMR data are shown in FIG. 2.
EXAMPLE 7 preparation of Compound II
50g of the compound III obtained in example 3 was added to 200mL of tetrahydrofuran, cooled to 0 ℃ and then 21g of sodium hydroxide was dissolved in 384g of a sodium hypobromite (10%) solution and added dropwise to the reaction system. And (3) reacting at 0-5 ℃, tracking by TLC until the reaction is finished, adding 58g of di-tert-butyl dicarbonate, tracking by TLC until the reaction is finished, extracting by using dichloromethane, and concentrating to dryness to obtain 63g of a crude product of the compound II, wherein the crude product is directly used in the next step.
EXAMPLE 8 preparation of Compound I
66g of the compound II prepared in example 6 were added to 120mL of tetrahydrofuran, and then 120mL of 0.5mol/L dilute sulfuric acid was added, stirred at room temperature for 20 hours, concentrated to remove tetrahydrofuran, cooled, filtered, washed, and dried to obtain 43g of a white solid, yield 87% (total of two steps), and purity 99%.1The H NMR data are shown in FIG. 3.
EXAMPLE 9 preparation of Compound I
63g of the compound II prepared in example 7 was added to 120mL of tetrahydrofuran, 120mL of 1mol/L diluted hydrochloric acid was added, the mixture was stirred at room temperature for 20 hours, the tetrahydrofuran was removed by concentration, and the mixture was cooled, filtered, washed and dried to obtain 47g of a white solid, yield 81% (total of the two steps) and purity 99%.
Claims (8)
1. A process for the preparation of the compound tert-butyl 3-oxocyclobutylcarbamate (compound I), comprising the steps of:
step a): the compound IV is protected to generate a compound III,
step b): carrying out Hoffman degradation reaction on the compound III to obtain a compound II,
step c): deprotecting compound II to produce compound I;
the specific route is as follows:
wherein R is halogen substituted or unsubstituted C1-C6 alkyl, unsubstituted C3-C6 cycloalkyl, unsubstituted benzyl, or benzyl substituted with halogen.
2. The method of claim 1, wherein: reacting the compound IV in the step a) with trimethyl orthoformate or triethyl orthoformate to obtain a compound III.
3. The method of claim 1, wherein: step a) is carried out under the action of a catalyst selected from sulfuric acid, p-toluenesulfonic acid, benzenesulfonic acid and acetic acid.
4. The method of claim 1, wherein: using an oxidant in the Hofmann degradation reaction in the step b), wherein the oxidant is selected from NaClO, NaBrO and Br2/NaOH。
5. The method of claim 1, wherein: the Hofmann degradation reaction in the step b) is carried out in an organic solvent, wherein the organic solvent is selected from tetrahydrofuran, dichloromethane and 1, 4-dioxane.
6. The method of claim 1, wherein: and c) carrying out deprotection reaction under the condition of an acid catalyst, wherein the acid catalyst is selected from hydrochloric acid and sulfuric acid.
7. The method of claim 1, wherein: the concentration of the acid in the deprotection reaction in the step c) is selected from 0.1-1 mol/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910360376.6A CN111848423B (en) | 2019-04-30 | 2019-04-30 | Preparation method of tert-butyl 3-oxocyclobutylcarbamate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910360376.6A CN111848423B (en) | 2019-04-30 | 2019-04-30 | Preparation method of tert-butyl 3-oxocyclobutylcarbamate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111848423A true CN111848423A (en) | 2020-10-30 |
CN111848423B CN111848423B (en) | 2022-10-14 |
Family
ID=72966507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910360376.6A Active CN111848423B (en) | 2019-04-30 | 2019-04-30 | Preparation method of tert-butyl 3-oxocyclobutylcarbamate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111848423B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024140678A1 (en) * | 2022-12-27 | 2024-07-04 | Beigene (Suzhou) Co., Ltd. | A ketal protected intermediate for sonrotoclax and preparation method thereof |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064961A (en) * | 1989-12-18 | 1991-11-12 | E. R. Squibb & Sons, Inc. | Process for preparing an optically active cyclobutane nucleoside |
EP1170281A1 (en) * | 2000-06-27 | 2002-01-09 | Les Laboratoires Servier | 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof |
WO2004056725A1 (en) * | 2002-12-20 | 2004-07-08 | Ge Healthcare Limited | Solid-phase preparation of 18f-labelled amino acids |
CN101070322A (en) * | 2007-03-26 | 2007-11-14 | 中国医学科学院医药生物技术研究所 | 7-(4-nitroyl-3-amino-1-piperidyl) quinolinecarboxylic acid derivative, its preparing method and use |
US20080280879A1 (en) * | 2007-05-09 | 2008-11-13 | Pfizer Inc | Substituted heterocyclic derivatives and their pharmaceutical use and compositions |
CN104244932A (en) * | 2011-10-19 | 2014-12-24 | 马尔斯公司 | Inhibitors of arginase and their therapeutic applications |
CN105130879A (en) * | 2015-07-24 | 2015-12-09 | 沧州那瑞化学科技有限公司 | Preparation method of (R)-3-Boc-aminopiperidine |
WO2016008582A1 (en) * | 2014-07-15 | 2016-01-21 | Grünenthal GmbH | Substituted azaspiro(4.5)decane derivatives |
CN105315161A (en) * | 2015-06-05 | 2016-02-10 | 厦门医学高等专科学校 | Method for preparing key intermediate of PKB/Akt inhibitor |
WO2017019487A1 (en) * | 2015-07-24 | 2017-02-02 | Celgene Corporation | Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein |
WO2017065473A1 (en) * | 2015-10-12 | 2017-04-20 | Chong Kun Dang Pharmaceutical Corp. | Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
CN107253940A (en) * | 2017-07-21 | 2017-10-17 | 苏州信恩医药科技有限公司 | Application of the asymmetric o conjugate addition reactions in the synthesis of Ao Gelieting intermediates |
CN109053496A (en) * | 2018-08-09 | 2018-12-21 | 吉尔生化(上海)有限公司 | A kind of synthetic method of 3-Boc- aminomethyl cyclobutanone |
CN112236415A (en) * | 2017-12-26 | 2021-01-15 | 赛特凯恩蒂克公司 | Process for preparing aminopyrimidines and intermediates thereof |
-
2019
- 2019-04-30 CN CN201910360376.6A patent/CN111848423B/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064961A (en) * | 1989-12-18 | 1991-11-12 | E. R. Squibb & Sons, Inc. | Process for preparing an optically active cyclobutane nucleoside |
EP1170281A1 (en) * | 2000-06-27 | 2002-01-09 | Les Laboratoires Servier | 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof |
WO2004056725A1 (en) * | 2002-12-20 | 2004-07-08 | Ge Healthcare Limited | Solid-phase preparation of 18f-labelled amino acids |
CN101070322A (en) * | 2007-03-26 | 2007-11-14 | 中国医学科学院医药生物技术研究所 | 7-(4-nitroyl-3-amino-1-piperidyl) quinolinecarboxylic acid derivative, its preparing method and use |
US20080280879A1 (en) * | 2007-05-09 | 2008-11-13 | Pfizer Inc | Substituted heterocyclic derivatives and their pharmaceutical use and compositions |
CN104244932A (en) * | 2011-10-19 | 2014-12-24 | 马尔斯公司 | Inhibitors of arginase and their therapeutic applications |
WO2016008582A1 (en) * | 2014-07-15 | 2016-01-21 | Grünenthal GmbH | Substituted azaspiro(4.5)decane derivatives |
CN105315161A (en) * | 2015-06-05 | 2016-02-10 | 厦门医学高等专科学校 | Method for preparing key intermediate of PKB/Akt inhibitor |
CN105130879A (en) * | 2015-07-24 | 2015-12-09 | 沧州那瑞化学科技有限公司 | Preparation method of (R)-3-Boc-aminopiperidine |
WO2017019487A1 (en) * | 2015-07-24 | 2017-02-02 | Celgene Corporation | Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein |
WO2017065473A1 (en) * | 2015-10-12 | 2017-04-20 | Chong Kun Dang Pharmaceutical Corp. | Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
CN107253940A (en) * | 2017-07-21 | 2017-10-17 | 苏州信恩医药科技有限公司 | Application of the asymmetric o conjugate addition reactions in the synthesis of Ao Gelieting intermediates |
CN112236415A (en) * | 2017-12-26 | 2021-01-15 | 赛特凯恩蒂克公司 | Process for preparing aminopyrimidines and intermediates thereof |
CN109053496A (en) * | 2018-08-09 | 2018-12-21 | 吉尔生化(上海)有限公司 | A kind of synthetic method of 3-Boc- aminomethyl cyclobutanone |
Non-Patent Citations (2)
Title |
---|
FREDERICK F. CASERIO等: "Small-ring compounds.XXI. 3-Methylenecyclobutanone and related compounds", 《3-METHYLENECYCLOBUTANONE》 * |
GREGORY S. BISACCHI等: "Synthesis and antiviral activity of anantiomeric forms of cyclobutyl nucleoside analogues", 《J. MED. CHEM.》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024140678A1 (en) * | 2022-12-27 | 2024-07-04 | Beigene (Suzhou) Co., Ltd. | A ketal protected intermediate for sonrotoclax and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN111848423B (en) | 2022-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101115412B1 (en) | New preparation of hydroxychloroquine | |
CN109516998B (en) | Synthesis method of Barosavir intermediate | |
JP2009502814A (en) | Production of N-substituted isothiazolinone derivatives | |
EA036663B1 (en) | Method for preparing azoxystrobin | |
CN113072436A (en) | Preparation method of benzyl aryl ether | |
CN111848423B (en) | Preparation method of tert-butyl 3-oxocyclobutylcarbamate | |
CN111302966A (en) | Preparation method of mirabegron intermediate | |
CN107868033B (en) | Preparation method of phenylalanine compound | |
CN111004141B (en) | New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide | |
CN111018782B (en) | Preparation method of 9-aminoacridine and derivatives thereof | |
JP2015526507A (en) | Method for purifying fluvoxamine free base and method for producing high purity fluvoxamine maleate using the same | |
CN114560862A (en) | Synthesis method of pyrrolo [1,2-A ] quinoxaline-4 (5H) -ketone and derivative thereof | |
CN113461538A (en) | Preparation method of 2-chloro-3-bromoaniline | |
CN114195684B (en) | Synthesis method of amino protecting group N-substituted chiral amino acid | |
KR100881890B1 (en) | Method for preparing safogrelate hydrochloride | |
AU2020259813A1 (en) | Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives | |
CN110724098A (en) | Synthetic method of 5, 7-dichloro-1, 2,3, 4-tetrahydroisoquinoline-6-carboxylic acid hydrochloride | |
CN112341406B (en) | Synthesis method of trans-4- [4- (3-methoxy-4-nitrophenyl) -1-piperazinyl ] adamantane-1-ol | |
CN113387874B (en) | Method for synthesizing 6, 6-dialkyl piperidine-2-carboxylic acid compound | |
CN111217709A (en) | Preparation method of (1-fluorocyclopropyl) methylamine hydrochloride | |
JP2003119197A (en) | Method for producing 2-amino-6-cyclopropylamino-9h- purine | |
US4338259A (en) | Alpha-halogeno-beta-aminopropionitriles or the mineral acid salts thereof, and processes for production thereof | |
CN119350202A (en) | Preparation method of 4-cyanophenyl isothiocyanate | |
CN118994060A (en) | Method for green synthesis of amide derivatives by using trichlorotoluene | |
CN113735693A (en) | Synthesis method of resveratrol monomethyl ether |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |